Introduction
Advancements in cardiovascular prevention and management continue to improve survival and progressively shift the burden of disease toward comorbidities such as cognitive impairment. Even mild cognitive impairment (MCI)-defined by deficits in objectively assessed cognitive function but no apparent impact on activities of daily living-is associated with reduced quality of life and poor prognosis (including dementia and death). 1, 2 Notwithstanding its clinical importance, MCI continues to be under-recognized and under-treated. Chronic heart disease-particularly in an advanced form sufficient to cause the clinical syndrome of heart failure (CHF)-is now widely recognized as an antecedent of MCI. 2, 3 However, the disproportionately high prevalence of MCI with key CHF predecessors (e.g. coronary artery disease, atrial fibrillation, hypertension and type 2 diabetes) 4 points to cognition also being affected during the evolution of CHF. In this context of subclinical (i.e. asymptomatic) disease, MCI may reflect the consequences of distinct cardiac structural and/or functional abnormalities readily detectable from echocardiography and/or other non-invasive imaging modalities. 5 Several studies have indeed reported on the predictive capacity of broad-based haemodynamic factors (e.g. cardiac output) for cognitive function 6, 7 ; however, compensatory mechanisms tend to maintain these parameters within a normal range until the onset of relatively advanced CHF. Thus, in the setting of subclinical disease, cardiac involvement in MCI is more likely to reflect early manifestations of left-ventricular (LV) impairment such as LV hypertrophy and/or diastolic dysfunction. However, these factors have only been investigated at the population level, with inconsistent results. 8, 9 In the present study, we examined MCI in the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) Study-a trial directed at prevention of clinical CHF in high-risk individuals. 10 Specifically, we sought the prevalence of MCI [measured via the Montreal Cognitive Assessment (MoCA) tool] 11 and its associations with echocardiographically determined cardiac structure and function (particularly LV geometry and diastolic function).
Methods

Study cohort
Detailed methods for the NIL-CHF Study (Australian New Zealand Clinical Trials Registry No. 12608000022369) have been described previously. 10, 12 The trial was designed to evaluate an intervention to prevent clinical CHF in high-risk individuals during 3-5 years follow-up. Briefly, cardiac inpatients at an Australian tertiary referral hospital were eligible for enrolment if they were aged > _45 years and were hospitalized with chronic heart disease but without evidence of clinical CHF. Congenital conditions, significant valve disease, terminal malignancy, or subsequent acute cardiac events within 30 days of hospital discharge (including acute heart failure), mandated exclusion from the study. Of 611 patients comprising the NIL-CHF Study intention-to-treat population, 454 (all Englishspeaking and without clinical CHF or asymptomatic systolic dysfunction at the time of examination) completed the MoCA, underwent echocardiographic examination for cardiac function, and were clinically profiled. Exclusion of patients with cerebrovascular disease (n = 81) left a final study cohort of n = 373. Data for 298 of these patients were taken from the baseline assessment performed one-month post-hospital discharge, with the remaining 75 patients' data collected at 36-month follow-up. The study was approved by the Alfred Hospital Human Research Ethics Committee and all patients provided written informed consent.
Clinical profiling
Standard demographic and clinical data were recorded at study entry (including age, sex, education level, medical history, and current medication regimen). 18 ; and (iv) elevated LV filling pressure estimated from both E/e 0 and LA volume index (i.e. E/e 0 ratio > _15 or >8 with concurrent LA enlargement). Analyses involving variables derived from LA volume were restricted to the 315 patients (84%) with available data.
Assessment of cognitive function
The MoCA is a validated one-page screening tool for MCI that was completed in-person by trained personnel. 11 It assesses a number of cognitive domains: short-term and working memory, visuoconstructional abilities, executive functioning, sustained attention and concentration, language abilities, and orientation. The total score out of 30-to which one point is added for < _12 years formal education-reflects global cognition. MCI was indicated by a score <26. 11 Deficits in each of the six constituent 
Statistical analyses
Analyses were undertaken using IBM SPSS Statistics version 22.0 (IBM Corp, Armonk, NY, USA). Unless otherwise specified, missing data for all variables was <5% and P <0.05 defined statistical significance. Continuous variables were expressed as mean ± standard deviation (SD) or median with interquartile range, depending on normality of distribution (Kolmogorov-Smirnov test). Categorical data were expressed as percentages. Group comparisons of continuous and categorical variables were performed using unpaired t-and v 2 -tests, respectively. Where adjustment for covariate(s) was required, analysis of covariance (ANCOVA; continuous variables) or binary/multinomial logistic regression (categorical variables) were applied.
Multivariate logistic regression (enter method) was used to examine independent associations of cardiac structure/function with MCI. An initial model featuring global cardiac status (i.e. 'diastolic dysfunction' and 'other cardiac abnormality' categories vs. 'normal') was considered the primary analysis. This was based on: (i) enabling of a direct comparison of the adjusted odds of MCI in the presence of functional, as opposed to structural abnormalities; and (ii) global cardiac status being considered the most robust indicator of subclinical cardiac disease given its integration of multiple echocardiographic parameters. Secondary analyses sought associations between MCI and individual echocardiographic parameters (separate models for each to avoid collinearity). Table 1 . Since those with MCI were older, comparisons of other variables were made with and without age-adjustment. The presence of MCI was characterized by more prevalent depressive symptoms, smoking, and poor dietary habits, less frequent alcohol consumption, and higher carotid IMT (where each of these group differences remained at least borderline significant after age-adjustment). The higher rate of atrial fibrillation in patients with MCI, along with their lower BMI and diastolic BP (and corresponding higher pulse pressure) became non-significant after age-adjustment.
Results
MCI was identified in 161 patients
MCI and global cardiac status (primary analysis)
In the primary multiple logistic regression model, the following covariates were entered alongside global cardiac status: age, sex, and education, variables found to be associated with MCI independent of age (i.e. depressive symptoms, smoking, poor dietary habits, and alcohol consumption-per Table 1 ) and other factors with recognized relationships to cognitive function (i.e. diabetes, 19 atrial fibrillation 20 and associated therapy, 21 physical activity, 22 and pulse pressure 23 ). With respect to atrial fibrillation therapy, we favoured model adjustment for anticoagulation since it predicted MCI and resulted in a better model fit compared with adjustment for antiplatelet or antithrombotic (i.e. composite of antiplatelet and/or anticoagulation) therapy. In addition, we collapsed the physical activity categories of 'moderate' and 'high' into a binary variable since this also improved model fit.
As shown in Figure 1 , both diastolic dysfunction and other cardiac abnormalities (vs. normal) were independently associated with MCI-the latter being borderline significant.
Concurrent predictors of MCI were older age, atrial fibrillation, smoking, poor dietary habit (all P < 0.05) and depressive symptoms (trend only; P = 0.073). Anticoagulant therapy and moderate alcohol intake demonstrated borderline significant reduced odds of MCI. In subsequent sensitivity analyses, additional adjustment for coronary artery disease, BMI, MAP, and carotid IMT did not substantively impact results (data not shown).
MCI and specific cardiac structural/ functional markers
Echocardiographic parameters according to MCI status are displayed in Table 2 (with and without age-adjustment). The predictive capacity of these parameters for MCI (with and without adjustment for the same covariates outlined in the primary analysis) is reported in Table 3 .
Cardiac structure Consistent with the higher prevalence of 'other cardiac abnormalities' relative to 'Normal', patients with MCI demonstrated significantly greater relative wall thickness and a trend toward higher LV mass index; however, on an age-adjusted basis, none of these group differences were significant ( Table 2 ). In the fully-adjusted prediction models (Table 3) , no associations were apparent between MCI and LV hypertrophy; nor LV mass index and relative wall thickness expressed as continuous variables.
Cardiac diastolic function
Poorer values for all individual diastolic functional markers (i.e. e 0 ,
E/e 0 , LA volume index, and derived markers of LV filling pressure)
were observed in the group with MCI ( Table 2) . With the exception of E/e 0 (when expressed categorically) and e 0 itself, these differences appeared largely independent of age (i.e. at least borderline significant post-adjustment). With full adjustment ( Associations of cardiac structure/ function with deficits in specific cognitive domains
The proportions of patients with deficits in specific cognitive domains are displayed in Figure 2 . Short-term/working memory was affected in the majority of the cohort (regardless of MCI). The next most commonly observed impairments were in executive functioning and visuoconstructional abilities (>70% of patients with MCI vs. <50% without MCI). Conversely, orientation domain scores indicated largely preserved function (deficit rate <20% in each group).
Of the six MoCA domains, global cardiac status was related to deficits in executive functioning (v 2 , P = 0.002) and visuoconstructional abilities (v 2 , P = 0.009), but not to language ability, short-term/ working memory, sustained attention/concentration, or orientation.
Mild cognitive impairment is associated with subclinical diastolic dysfunction
Detailed data are shown in Supplementary data online, (Table S1) . Diastolic dysfunction was a predictor of deficits in both executive functioning and visuoconstructional abilities (i.e. unadjusted, as well as in multivariate analyses featuring the same covariates described for aforementioned MCI prediction models; Figure 1) . In contrast, classification in the 'other cardiac abnormality' category predicted a visuoconstructional ability deficit, but was unrelated to executive functioning. E/e 0 expressed as a continuous variable was an independent predictor of executive functioning, but not visuoconstructional ability.
Discussion
To our knowledge, this is the first report linking diastolic dysfunction with MCI in patients with subclinical chronic heart disease at high-risk of developing the clinical CHF syndrome. We found that the Indicates log-transformed data used for t-test/analysis of covariance (due to skewed distribution).
prevalence of MCI was relatively high (43%) in this setting. In turn, those with evidence of LV diastolic dysfunction based on sensitive echocardiographic markers demonstrated odds of concurrent MCI that were approximately two-times higher than for individuals with normal cardiac function, even after adjustment for age, sex, and other relevant clinical covariates. Collectively, these findings suggest links between cardiac and cognitive function not only with advanced disease associated with impairment of cardiac haemodynamics, but also at earlier, subclinical stages within the evolution of CHF.
Cognitive impairment in cardiac disease
Cognitive screening with the MoCA tool indicated MCI in almost half of the current cohort. This should be generalizable to the broader subclinical CHF population given our study's relatively unrestrictive eligibility criteria. Indeed, reported prevalence is likely to be conservative given that patients with cerebrovascular disease and systolic dysfunction were excluded. That MCI is a more frequent finding in those at risk of clinical CHF compared with the general older population (where prevalence estimates span 10-20% in those >65 years), 1 is not unexpected given previous reports of poorer cognitive function in association with individual CHF antecedents on which enrolment in the NIL-CHF study was based (i.e. coronary artery disease, . Age-adjusted P-values are based on analysis of covariance (continuous variables) or binary/multinomial logistic regression (categorical variables). e 0 , early diastolic septal annular velocity; E/e 0 , ratio of early diastolic filling and septal annular velocities; LA, left-atrial; LV, left-ventricular; MCI, mild cognitive impairment.
a Indicates log-transformed data used for t-test/analysis of covariance (due to skewed distribution).
b LA volume measurements available in a subgroup only (n = 315; 84%). Deficits in specific cognitive domains in the current cohort were most prevalent for short-term/working memory, followed by executive functioning and visuoconstructional abilities; however, relationships with cardiac function were detected only for the latter two. These findings are largely consistent with previous investigations of cognitive function in cardiometabolic disease, which point to executive functioning-a domain with major implications for disease management-being particularly vulnerable to deterioration. 3 
Cognitive impairment and LV dysfunction
Cognitive impairment is a widely recognized adjunct of clinical CHF and several lines of evidence suggest that this reflects the haemodynamic consequences of CHF, rather than shared risk profiles alone. To date, this evidence has overwhelmingly come from studies in preestablished clinical CHF associated with concurrent systolic dysfunction (i.e. reduced ejection fraction), which may coincide with cerebral hypoperfusion and correlate with the severity of cognitive decline. 2, 3, 24 Perhaps for this reason, existing literature linking cognitive impairment with specific cardiac characteristics-not just in CHF, but also in population-based studies-has focused heavily on markers mainly reflective of LV systolic function. 3, 5 Although diastolic function and geometric factors were investigated in the Hoorn 9 and
Southall and Brent Revisited (SABRE) 8 cohorts, these were population-based and thus inclusive of individuals with reduced ejection fraction (both symptomatic and subclinical). To our knowledge, the current analysis is the first to address whether MCI is linked to diastolic dysfunction, hypertrophy, and/or other early markers of LV damage after removing the confounding haemodynamic consequences of systolic dysfunction. A key finding was the over-representation of diastolic dysfunction in the subgroup with MCI. This association was evident for diastolic dysfunction per se (i.e. primary analysis of global cardiac status), as well as markers of LV filling pressure.
Importantly, both diastolic dysfunction and E/e 0 predicted MCI independently of relevant clinical covariates. This finding is significant in its advocacy of diastolic dysfunction at least as a risk marker for MCI, but potentially also as a risk factor and therapeutic target. The predictive capacity of diastolic dysfunction for global MCI appeared to primarily reflect associations with executive functioning and visuoconstructional abilities (i.e. there was no relationship with the domains of memory, attention, language or orientation). This is largely concordant with the Hoorn study, in which LV diastolic markers were related to executive functioning, but not memory. 9 In the SABRE cohort, diastolic dysfunction (classified as per the current study) was unrelated to global and domain-specific indices of cognitive function, though markers of LV filling pressure (E/e 0 and LA 8 Aside from methodological differences between studies (particularly with respect to cognitive assessment modality), we contend that these divergent findings probably reflect variation in the relative importance of diastolic function for cognition across different clinical contexts. Despite LV hypertrophy frequently coexisting with diastolic dysfunction, it contrarily demonstrated no significant relationship with MCI. This result adds to a conflicting body of evidence pertaining to LV mass and its relationship with cognition, 9, 25, 26 which may reflect between-study differences in patient population and extent of covariate adjustment. Our exclusivity to subclinical CHF probably limited our capacity to detect an association that may exist across a broader range of disease severity.
Possible mechanisms
Since this study did not attempt to interrogate causality or mechanisms, it must be acknowledged that-despite statistical adjustment for a number of potential covariates-diastolic and cognitive decline may simply represent parallel processes arising from a number of shared risk factors. However, plausible links between diastolic dysfunction and MCI for future investigation include coincident arterial stiffening and blunting of cardiac functional reserve, both of which predispose to cerebral circulatory dysfunction. Given we excluded stroke and adjusted for carotid IMT, a role for macrovascular disease is unlikely. Microvascular disease on the other hand may be relevant in the context of associations between LV dysfunction and white matter hyperintensity (WMH) volume 27 ; however, in the absence of WMH and other microvascular indices modifying associations between diastolic and cognitive function in the SABRE study, 8 this would appear an incomplete explanation.
Study limitations
Methodological drawbacks include reliance on a single screening tool for MCI rather than comprehensive assessments of specific cognitive domains. Since the cross-sectional design precludes causal assumptions, longitudinal and/or prospective trial data will be necessary to determine the extent to which observed associations reflect mechanistic links and/or common risk pathways. Given sample size requirements for multivariate analyses, we did not investigate whether independent associations in the full cohort were consistent across relevant subgroups. This also precluded adjustment for other potential MCI antecedents. Finally, it is unclear whether our findings will be generalizable to non-ischaemic disease since coronary artery disease represented the predominant CHF antecedent.
Conclusions
The present study points to a high burden of MCI in patients with chronic heart disease at high-risk of CHF. This supports the contention that even subclinical cardiac disease has an adverse impact on cognitive function. Indeed, our data indicate that the odds of MCI are two times higher in patients with diastolic dysfunction compared to those with normal cardiac structure/function. Further work is warranted to determine the potential role of diastolic dysfunction in MCI risk prediction and its value as a therapeutic target.
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